Physiologically based pharmacokinetic modeling supports investigation of potential drug-drug interactions in the pre- and early post-hematopoietic stem cell transplantation stages

Ítems similars

• Population Pharmacokinetics of Mycophenolic Acid in Renal Transplant Patients: A Comparison of the Early and Stable Posttransplant Stages
  per: Peile Wang, et al.
  Publicat: (2022-05-01)
• Unravelling bisphenol A pharmacokinetics using physiologically based pharmacokinetic modeling
  per: Xiaoxia eYang, et al.
  Publicat: (2015-01-01)
• Prediction of Pharmacokinetics for CYP3A4-Metabolized Drugs in Pediatrics and Geriatrics Using Dynamic Age-Dependent Physiologically Based Pharmacokinetic Models
  per: Jing Han, et al.
  Publicat: (2025-02-01)
• Evaluation of Drug–Drug Interactions Between Clarithromycin and Direct Oral Anticoagulants Using Physiologically Based Pharmacokinetic Models
  per: Zhuan Yang, et al.
  Publicat: (2024-11-01)
• Prediction of pharmacokinetic/pharmacodynamic properties of aldosterone synthase inhibitors at drug discovery stage using an artificial intelligence-physiologically based pharmacokinetic model
  per: Mengjun Zhang, et al.
  Publicat: (2025-04-01)